Novartis AG (NVS) is in Healthcare, Drug Manufacturers - General, based in Switzerland, listed on NYSE. Market cap 272.01B USD. 52-week range 121.57 to 170.46 USD. Trailing P/E 21.6. Data as of 2026-10-09.
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 ...